Browsing: SinoMab

SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy

By Marie JonesApril 17, 20240

SinoMab BioScience Limited (HKG: 3681, SinoMab or the Company), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing…

HealthCare

SinoMab entered into Strategic Collaboration with D2M

By Marie JonesJuly 23, 20200

SinoMab BioScience Limited (“SinoMab” of the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development,…